Breakthrough in Colorectal Cancer Research
Recent advancements in colorectal cancer research have emerged from South Korea, particularly concerning a disease that ranks as the second most prevalent cause of cancer-related deaths in the United States.
Colorectal cancer occurs when abnormal cell growth occurs in the lining of the large intestine. The recent deaths of notable figures, such as James Van Der Beek and Catherine O’Hara, have highlighted the severe dangers associated with this illness, as well as the potential link to processed foods.
One individual raised a valid point, asking, “Why aren’t we banning the same ingredients as Europe does?”
Research Findings on Colorectal Cancer
A team of researchers in South Korea has identified a method to slow the progression of colorectal cancer, as outlined in a study published in Nucleic Acids Research on January 14, 2026. They discovered that inhibiting a specific protein could decelerate the cancer spread.
The research indicated that silencing a gene named N-methyl-D-aspartate receptor synaptonuclear signaling and neuronal migration factor (NSMF) could lead to “irreversible cellular aging” in tumors.
NSMF has been characterized as an important regulator of replication stress, enabling cancerous cells to divide quickly, which in turn contributes to DNA damage and mutation development.
Experiments conducted in labs and on mice revealed that disabling the NSMF gene could reduce tumor growth significantly—sometimes halting it entirely—by inducing a state of permanent cell aging.
Interestingly, this approach did not appear to adversely affect healthy intestinal cells in the mice, unlike chemotherapy, which often harms non-cancerous cells.
Dr. Kyeong Jin Shin, who led the study from the Ulsan National Institute of Science and Technology, expressed optimism regarding the potential to develop treatments that inhibit this protein for human use.
Alarming Increase in Colon Cancer Among Younger Adults
According to Dr. Céline Gounder, colon cancer has become the leading cause of cancer-related deaths among individuals under the age of 50 in the United States. Overall, it ranks third in men and fourth in women for cancer fatalities. Estimates indicate that colorectal cancer could claim approximately 55,230 lives this year alone.
Although early screening has successfully reduced colorectal cancer diagnoses among older adults, younger populations have not benefited similarly. From 2013 to 2022, cases among those under 50 increased by 2.9% annually, while the rate for adults aged 50 to 64 saw only a modest rise of 0.4% per year.
Dr. Gounder emphasized the importance of screening, noting that lifestyle factors, diet, and family medical history contribute to increased risk, but the late detection of the disease often leads to tragic outcomes.
Given the recent spikes in colon cancer rates for younger individuals, the US Preventive Services Task Force has even considered lowering the screening age from 50 to 45.
Public Response Following Recent Deaths
Following the fatalities of Van Der Beek and O’Hara, there has reportedly been a notable surge in individuals seeking colorectal cancer screenings. Medical reports revealed that O’Hara succumbed to rectal cancer, leading to complications like a pulmonary embolism.
Van Der Beek, diagnosed with colorectal cancer in 2023, had initially mistaken his symptoms as a result of increased coffee consumption and a sedentary lifestyle.
Since the actors’ passing, the Colorectal Cancer Alliance noted that the usage of their complimentary screening tool has skyrocketed.
The discourse surrounding these tragedies has also expanded on social media, with many urging for preventive measures against colorectal cancer. Comments reflecting this concern range widely, emphasizing the importance of early screenings and awareness.
“Don’t wait till 45 to get checked,” someone remarked, highlighting the urgency for early detection.
